Overview

22nd Century Group, Inc. is a biotechnology company focused on developing reduced nicotine tobacco and hemp/cannabis plant lines, with the aim of reducing the harm associated with tobacco and cannabis use. The company utilizes genetic engineering and plant breeding technologies to achieve these goals.

Therapeutic areas

Plant BiotechnologyTobacco Harm ReductionCannabis

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to 22nd Century Group, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this 22nd Century Group, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.